Genetic Epilepsy with Febrile Seizures Plus (GEFS+) Clinical Trials

Find Genetic Epilepsy with Febrile Seizures Plus (GEFS+) Clinical Trials Near You

Impact d'Une Fiche Explicative donnée Aux Parents après Une première Consultation Pour Crise fébrile Simple au Service d'Accueil Des Urgences pédiatriques du CHU de Strasbourg

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Simple febrile seizures (SFS) are a very common phenomenon (2-5% of children), mostly without serious consequences for the child or their development, but extremely anxiety-provoking for parents, who develop a fear of fever for fear of a recurrence, and request numerous additional tests, not justified according to current guidelines, after a first episode of SFS. Educating parents about these fever-related crises and fever management, and standardizing the information provided through an explanatory sheet implemented at the SAUP in July 2023, would help reduce consultations for recurrent simple febrile crises, as well as early consultations for isolated fever (reflecting parental anxiety caused by these crises).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 9 months
Maximum Age: 5
Healthy Volunteers: f
View:

• Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit)

• First visit to the SAUP for a simple febrile seizure

• Meeting the clinical criteria for FCS:

‣ Generalized seizure lasting less than 15 minutes

⁃ No post-critical deficit

⁃ No recurrence of seizures within 24 hours

⁃ No personal history of neurological disorders

• Occurrence between January 1, 2022, and May 1, 2025

• First or second episode of FSFS at the time of consultation

• Presence of one of the two parents during the consultation at the SAUP

Locations
Other Locations
France
Service de pédiatrie 1 - CHU de Strasbourg - France
RECRUITING
Strasbourg
Contact Information
Primary
Sarah Baer, MD
sarah.baer@chru-strasbourg.fr
33 3 88 12 63 98
Time Frame
Start Date: 2025-06-11
Estimated Completion Date: 2026-06-11
Participants
Target number of participants: 100
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov